Anti-Cancer Biologics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT05979298
Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 15, 2019
Completion: Dec 30, 2024
Loading map...